|
|
View Clinical Trial (Medical Research Study)
|
TearLab Core Validation Study - NCT00848198-63017B (Clinical Trial 273469)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy273469.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
Kansas City |
|
State:
|
|
MO |
| Zip Code: |
|
63017 |
| Conditions: |
|
Dry Eye Disease |
| Purpose: |
|
This is a global study of tear osmolarity using the OcuSense TearLab technology to compare
tear samples of age and sex-matched normals with those with Dry Eye Disease (DED).
Diagnosis of DED subjects will be established using objective and subjective tests.
Positive responses to 3 out of 6 defined criteria determine subjects with DED. DED subjects
will be further categorized by severity, using results from the objective and subjective
tests. Subjects will be assessed at a single visit.
|
| Study summary: |
|
This is a multicenter study. A total of 500 subjects are expected to be enrolled at 10
sites located in the United States, Europe and Japan. It is anticipated that each site will
enroll approximately 50 subjects.
Objectives:
- Primary: To establish OcuSense TearLab Osmometry (OTO) normative values, and referent
values to diagnose dry eye disease (DED)
- Secondary:
- To establish the relationship between OTO values and the severity of DED.
- To assess the effect on diagnostic accuracy of adding additional categories of
diagnostic test results, e.g. Ocular Surface Disease Index (OSDI) and /or Tear
Break-up Film Test (TBUT).
- To assess the effect of age and sex on the range of OTO values in normal subjects.
- To establish the variance of right eye (RE)/left eye (LE) OTO values in normal subjects
and in subjects with DED.
- To establish the accuracy of single eye OTO values versus bilateral values in
diagnosing DED.
- To assess the range of OTO values in symptomatic subjects without signs of DED and in
DED subjects of varying severity as judged by the clinical severity scale. |
| Criteria: |
|
Inclusion Criteria:
- Be between the ages of 18 and 79 years of age.
- Must understand and be able, willing and likely to fully comply with study procedures
and restrictions.
Exclusion Criteria:
- Clinically significant eyelid deformity or eyelid movement disorder that is caused by
conditions such as notch deformity, incomplete lid closure, entropion, ectropion,
hordeola or chalazia..
- Previous ocular disease leaving sequelae or requiring current topical eye therapy
other than for Dry Eye Disease, including, but not limited to: active corneal or
conjunctival infection of the eye and ocular surface scarring.
- Active ocular allergy.
- LASIK or PRK surgery that was performed within one year of Visit 1.
- Started or changed the dose of chronic ocular medication within 30 days of visit 1.
- Contact lens worn within the past eight (8) hours.
- Any ophthalmologic drops within 2 hours of screening and visit 1 procedures.
- Pregnancy or lactation.
- Abnormality of nasolacrimal drainage (by history).
- Punctual plugs placement or cauterization within 30 days of Visit 1
- Started or changed the dose of chronic systemic medication known to affect tear
production including, but not limited to antihistamines, antidepressants, diuretics,
corticosteroids or immunomodulators within 30 days of Visit 1.
- Systemic disease known to affect tear production or loss including, but not limited
to thyroid eye disease, that has been diagnosed or has not been stable within 30 days
of Visit 1.
- Known hypersensitivity to any of the agents used in testing i.e. sodium fluorescein,
lissamine green, oxybuprocaine or proparacaine. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|